The reciprocal interaction between sleep and type 2 diabetes mellitus: Facts and perspectives

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 3, 2008, Pages 180-187

  Martins, R C ^a   Andersen, M L ^a   Tufik, S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apnea; Diabetes; Metabolic syndrome; Obesity; Sleep

Indexed keywords

CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOCRINE DISEASE; EPIDEMIC; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PREVALENCE; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SITTING; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP TIME; SYSTEMIC DISEASE;

EID: 44449128047     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000194     Document Type: Review

References (60)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. Birkeland KI, Berg JP. Type 2 diabetes - preventable, but how? Eur J Endocrinol 2001; 145: 573-575.
3. Mooradian AD. Diabetic complications of the central nervous system. Endocr Rev 1988; 9: 346-356.
4. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity. insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158.
5. Mander BA, Colecchia E, Spiegel K, Van Cauter EY. Short sleep: A risk factor for insulin resistance and obesity. Sleep 2001; 24 (Abstract A74).
6. Bonnet MH, Arand DL. We are chronically sleep depived, Sleep 1995; 18: 908-911.
7. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005; 99: 2008-2019.
8. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997; 18: 716-738.
9. Trenell MI, Marshall NS, Rogers NL. Sleep and metabolic control: waking to a problem? Clin Exp Pharmacol Physiol 2007: 34: 1-9.
10. Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003, 26: 702-709.
11. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
12. Czupryniak L, Saryusz-Wolska M, Pawlowski M, Wojcik J, Loba J. Distribution of the components of the NCEP ATP III-defined metabolic syndrome in newly diagnosed diabetes and non-diabetes Caucasian subjects; implications for metabolic syndrome prevention and treatment. Exp Clin Endocrinol Diabetes 2007; 115: 187-191.
13. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214.
14. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
15. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005; 126: 121-129.
16. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting, J Clin Invest 1996; 98: 1277-1282.
17. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004; 63: 135-142.
18. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829-839.
19. Polotsky VY, Wilson JA, Haines AS, Scharf MT, Soutiere SE, Tankersley CG, et al. The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med 2001; 163: 624-632.
20. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med 1999; 50: 387-400.
21. Bixler EO, Vgontzas AN, Lin HM, Ten HT, Rein J, Vela-Bueno A, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163: 608-613.
22. Guilleminault C, van den Hoed J, Mitler MM. Clinical overview of the steep apnea syndrome. In: Guilleminault C, Dement WC (Editors), Sleep apnea syndromes. New York: Alan R. Liss, Inc.; 1978. p 1-12.
23. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 279-289.
24. Lugaresi E, Cirignotta F, Geraldi R, Montagna P. Snorinig and sleep apnea: natural history of heavy snores disease. In: Guilleminault C, Partinen M (Editors), Obstructive sleep apnea syndrome. New York: Raven Press; 1990. p 25-36.
25. Lavie P. Sleep apnea in the presumably healthy working population - revisited. Sleep 2002; 25: 380-387.
26. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kates A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive steep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinot Metab 2001; 86: 517-520.
27. Lopes LA, Lins CM, Adeodato VG, Quental DP, de Bruin PF, Montenegro RM Jr, et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005; 28: 2633-2636.
28. Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 1998; 158: 1333-1337.
29. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
30. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-543.
31. Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res 1995; 3 (Suppl 4): 477S-480S.
32. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Steep apnea and sleep disruption in obese patients. Arch Intern Med 1994; 154: 1705-1711.
33. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32-44.
34. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26: 380-384.
35. Chrousos GP, Gold PW. A healthy body in a healthy mind - and vice versa - the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 1998, 83: 1842-1845.
36. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002. 165: 670-676.
37. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682.
38. Vgontzas AN, Bixler EO, Papanicolaou DA, Chrousos GP. Chronic systemic inflammation in overweight and obese adults. JAMA 2000; 283: 2235.
39. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354: 1435-1439.
40. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006; 61: 945-950.
41. Brooks B, Cistulli PA, Borkman M, Ross G, McGhee S. Grunstein RR, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-1685.
42. Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004; 169: 950-956.
43. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998; 157: 1098-1103.
44. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290: 1906-1914.
45. Van Cauter E, Knutson K, Leproult R, Spiegel K. The impact of sleep deprivation on hormones and metabolism. Medscape Neurol Neurosurg 2005; 7: 1-6.
46. Kripke DF, Simons RN, Garfinkel L, Hammond EC, Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 1979; 36: 103-116.
47. Sridhar GR, Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 1994; 23: 183-186.
48. Scheen AJ, Byrne MM, Plat L, Leproult R, Van Cauter E. Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol 1996; 271: E261-E270.
49. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9: 211-224.
50. Stumvoll M, Haring H insulin resistance and insulin sensitizers. Horm Res 2001: 55 (Suppl 2): 3-13.
51. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-2126.
52. Akerstedt T. Nilsson PM. Sleep as restitution: an introduction. J Intern Med 2003; 254: 6-12.
53. Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28: 2762-2767.
54. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM, Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
55. Kump K, Whalen C, Tishler PV, Browner I, Ferrette V, Strohl KP, et al. Assessment of the validity and utility of a sleep-symptom questionnaire. Am J Respir Crit Care Med 1994; 150: 735-741.
56. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 1997; 504 (Part 1): 241-249.
57. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, et al Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169:1231-1237.
58. Smith ML, Niedermaier ON, Hardy SM, Decker MJ, Strohl KP. Role of hypoxemia in sleep apnea-induced sympatho-excitation. J Auton Nerv Syst 1996; 56: 184-190.
59. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee? Chest 2004; 126: 1-2.
60. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005; 99: 1998-2007.